SCYX SCYNEXIS, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 10, 2026
$5,12
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,5752 haftanın en düşüğü
$6,1552 haftanın en yükseği
Piyasa Değeri (MRQ)
$51M
P/E (TTM)
17.7
Hisse Başına Kâr (TTM)
$0.29
Gelir (TTM)
$19M
rozetleriniz
52 Haftlık Aralık
$1–$6
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$36
P/E
17.7
ROE
-18.4%
Net Kâr Marjı
-53.3%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
SCYX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$5.12
Piyasa Değeri (MRQ)
$51M
P/E (TTM)
17.7
Hisse Başına Kâr (TTM)
$0.29
Gelir (TTM)
$19M
ROE (TTM)
-18.4%
52 Haftlık Aralık
$1–$6
SCYX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 01 Haziran 2026 | 1-for-8 | Ters |
| 17 Temmuz 2020 | 1-for-10 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$21M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-0.172016-12-31 → 2025-12-31
Serbest Nakit Akışı·2016-12-31 → 2020-12-31
Net kar marjı-53.3%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | SCYX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 17.75Y ort. ≈-2.2 | ≈-2.2 | · | · | |
| F/S (TTM) | 2.75Y ort. ≈6.1 | ≈6.1 | 34.3 | Düşük değerli | |
| F/D (MRQ) | 0.85Y ort. ≈4.6 | ≈4.6 | 1.7 | Düşük değerli | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -9.65Y ort. ≈-1.6 | ≈-1.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.05Y ort. ≈5.0 | ≈5.0 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | SCYX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -117.7%5Y ort. ≈-675.4% | ≈-675.4% | -3308.5% | Aynı seviyede | |
| EBITDA Margin (FAVÖK Marjı) | -78.0%5Y ort. ≈-675.4% | ≈-675.4% | -1707.4% | Ortalamanın altında | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -41.8%5Y ort. ≈-471.0% | ≈-471.0% | -113.6% | En üst düzey | |
| Net Kâr Marjı (TTM) | -53.3%5Y ort. ≈-449.0% | ≈-449.0% | -41.3% | En üst düzey | |
| ROA (TTM) | -15.1%5Y ort. ≈-7.4% | ≈-7.4% | -59.6% | En üst düzey | |
| ROE (TTM) | -18.4%5Y ort. ≈-147.3% | ≈-147.3% | -112.1% | En üst düzey | |
| ROIC | -32.6%5Y ort. ≈-617.2% | ≈-617.2% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | SCYX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 9.75Y ort. ≈5.2 | ≈5.2 | 3.3 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 7.05Y ort. ≈4.6 | ≈4.6 | 3.1 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | SCYX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 450.0%5Y ort. ≈736.0% | ≈736.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 59.4% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | SCYX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.4 | ≈0.4 | 0.0 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$1.1M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
26.4%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 17, 2026 | $0.63 | $-0.52 | 221.9% |
| 31 Mart 2026 | May 13, 2026 | $-3.36 | $-1.01 | -233.9% |
| 31 Aralık 2025 | $1.94 | $1.03 | 87.3% | |
| 30 Eylül 2025 | $-1.36 | $-1.63 | 16.7% | |
| 30 Haziran 2025 | $-1.12 | $-1.55 | 27.8% | |
| 31 Mart 2025 | $-0.11 | $-0.18 | 38.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $4M | $140M | $5M | $13M | $0 | $121.0K | $257.0K | $257.0K | $257.0K | $257.0K | $1M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $15M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| R&D Expense | $22M | $26M | $31M | $27M | $24M | $37M | $38M | $22M | $18M | $20M | $16M | $8M | |
| SG&A Expense | $14M | $14M | $21M | $63M | $50M | $15M | $11M | $9M | $8M | $8M | $12M | $8M | |
| Operating Expenses | $37M | $41M | $67M | $91M | $74M | $51M | $49M | $30M | $27M | $28M | $29M | $16M | |
| Operating Income | $-16M | $-37M | $73M | $-86M | $-61M | $-51M | $-49M | $-30M | $-26M | $-28M | $-28M | $-15M | |
| Interest Expense | · | · | $3M | $5M | $3M | $1M | $986.0K | $2M | $1M | $351.0K | $-11.0K | $48.0K | |
| Other Non-op | $7M | $16M | $-5M | $18M | $25M | $-7M | $-5M | $11M | $1M | $-2M | $0 | $-10.0K | |
| Pretax Income | $-9M | $-21M | $67M | $-68M | $-36M | $-58M | $-54M | $-19M | $-25M | $-30M | $-28M | $-7M | |
| Income Tax | $0 | $151.0K | $138.0K | $-5M | $-3M | $-3M | $0 | $-7M | $0 | $0 | $0 | $-1M | |
| Net Income | $-9M | $-21M | $67M | $-63M | $-33M | $-55M | $-54M | $-12M | $-25M | $-30M | $-33M | $-4M | |
| EPS (Basic) | $-0.17 | $-0.44 | $1.40 | $-1.47 | $-1.25 | · | · | · | · | $-1.58 | $-2.68 | $-1.04 | |
| EPS (Diluted) | $-0.17 | $-0.44 | $1.39 | $-1.47 | $-1.25 | · | · | · | · | $-1.58 | $-2.68 | $-2.69 | |
| Shares (Basic) | 49,933,381 | 48,513,073 | 47,852,833 | 42,613,510 | 26,384,713 | · | · | · | · | 19,035,299 | 12,163,559 | 5,663,311 | |
| Shares (Diluted) | 49,933,381 | 48,513,073 | 48,390,582 | 42,613,510 | 26,384,713 | · | · | · | · | 19,035,299 | 12,163,559 | 5,937,087 | |
| EBITDA | $-16M | $-37M | $73M | $-86M | · | $-51M | · | $-30M | $-26M | $-28M | $-28M | $-12M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $16M | $34M | $46M | $104M | $93M | $42M | $11M | $11M | $36M | $47M | $32M | |
| Short-term Investments | $19M | $43M | $40M | $28M | $0 | · | · | · | · | $23M | $0 | · | |
| Receivables | · | · | $0 | $2M | $861.0K | $0 | · | · | · | · | · | $1M | |
| Inventory | · | · | $0 | $899.0K | $463.0K | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $263.0K | $2M | $6M | $3M | $4M | $5M | $4M | $7M | $1M | $741.0K | $1M | $703.0K | |
| Other Current Assets | $17.0K | $1M | $5M | $62.0K | $4.0K | $373.0K | $674.0K | $54.0K | $91.0K | $41.0K | $38.0K | $3.0K | |
| Current Assets | $40M | $72M | $102M | $79M | $109M | $98M | $52M | $51M | $45M | $59M | $48M | $40M | |
| PP&E (Net) | · | · | · | · | $113.0K | $298.0K | $405.0K | $516.0K | $4.0K | · | $42.0K | $0 | |
| PP&E (Gross) | · | · | · | · | $580.0K | $580.0K | $577.0K | $577.0K | $12.0K | · | $42.0K | $22M | |
| Accum. Depreciation | · | · | · | · | $467.0K | $282.0K | $172.0K | $61.0K | $8.0K | · | $0 | $17M | |
| Intangibles | · | · | $0 | $408.0K | $1M | $0 | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $0 | $6M | $6M | $573.0K | $812.0K | $812.0K | $572.0K | $120.0K | $419.0K | $25.0K | |
| Total Assets | $59M | $91M | $128M | $88M | $120M | $103M | $57M | $53M | $46M | $60M | $49M | $40M | |
| Accounts Payable | $2M | $5M | $7M | $6M | $8M | $5M | $7M | $4M | $4M | $2M | $619.0K | $426.0K | |
| Accrued Liabilities | $3M | $4M | $7M | $6M | $6M | $4M | $4M | $2M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $6M | $24M | $16M | $18M | $14M | $26M | $11M | $6M | $10M | $4M | $7M | $5M | |
| Capital Leases | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $3M | $0 | · | · | · | · | · | · | |
| Total Liabilities | $10M | $36M | $55M | $85M | $79M | $80M | $44M | $22M | $24M | $25M | $7M | $6M | |
| Long-term Debt | · | · | · | · | $34M | · | · | $15M | $15M | $14M | · | · | |
| Total Debt | · | · | · | · | · | · | · | $15M | $15M | $14M | · | $0 | |
| Paid-in Capital | $435M | $432M | $428M | $425M | $401M | $349M | $284M | $249M | $227M | $215M | $192M | $151M | |
| Retained Earnings | $-385M | $-377M | $-355M | $-422M | $-359M | $-327M | $-271M | $-218M | $-205M | $-180M | $-150M | $-118M | |
| Stockholders' Equity | $49M | $55M | $73M | $3M | $41M | $23M | $13M | $31M | $21M | $35M | $42M | $33M | |
| Liabilities + Equity | $59M | $91M | $128M | $88M | $120M | $103M | $57M | $53M | $46M | $60M | $49M | $40M | |
| Shares Outstanding | 5,442,688 | 4,746,748 | 37,207,799 | 32,682,342 | 28,705,334 | 19,663,698 | 9,741,372 | 4,797,198 | 28,971,651 | 24,609,411 | 13,905,599 | 8,512,103 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $0 | $580.0K | $606.0K | $379.0K | $111.0K | · | · | · | · | · | · | |
| Stock-based Comp | $3M | $3M | $3M | $4M | $2M | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $400.0K | $700.0K | $200.0K | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-24M | $60M | $-80M | $-55M | $-49M | $-38M | $-28M | $-25M | $-29M | $-25M | $-9M | |
| CapEx | · | · | · | · | $0 | $4.0K | $0 | $565.0K | $2.0K | $27.0K | $589.0K | $704.0K | |
| Investing Cash Flow | $24M | $6M | $-35M | $-27M | $-1M | $6M | $26M | $-803.0K | $-10M | $-22M | $2M | $-488.0K | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $0 | $0 | · | |
| Stock Issued | $5.0K | $0 | $0 | $47M | $39M | $91M | $46M | $32M | $10M | $28M | $41M | $62M | |
| Net Stock Activity | $5.0K | · | $0 | $47M | · | $91M | · | $32M | $10M | $28M | $41M | $62M | |
| Financing Cash Flow | $-14M | $-139.0K | $-37M | $49M | $67M | $94M | $42M | $29M | $10M | $40M | $38M | $41M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-24M | $-11M | $15M | $31M | |
| Free Cash Flow | · | · | · | · | · | $-49M | · | $-29M | $-25M | $-29M | $-25M | $-10M | |
| Levered FCF | · | · | · | · | · | $-50M | · | $-30M | $-26M | $-30M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 18.8% | |
| Operating Margin | -78.0% | -990.8% | 51.8% | -1684.5% | · | · | · | -11666.5% | -10241.2% | -10823.7% | -11030.7% | -63.7% | |
| Net Margin | -41.8% | -568.3% | 47.8% | -1233.7% | · | · | · | -4851.4% | -9751.0% | -11668.9% | -12693.8% | -22.3% | |
| Pretax Margin | -41.8% | -564.3% | 47.9% | -1326.0% | · | · | · | -7472.4% | -9766.5% | -11668.9% | -11026.5% | · | |
| EBITDA Margin | -78.0% | -990.8% | 51.8% | -1684.5% | · | · | · | -11666.5% | -10241.2% | -10823.7% | -11030.7% | -63.7% | |
| ROA | -11.5% | -19.4% | 62.0% | -60.5% | · | -69.1% | · | -25.2% | -47.4% | -55.0% | -73.4% | -16.3% | |
| ROE | -18.4% | -37.5% | 81.3% | -614.5% | · | -341.5% | · | -42.2% | -103.0% | -78.1% | -86.6% | 11.3% | |
| ROIC | -32.6% | -67.9% | 99.4% | -2467.9% | · | -212.6% | · | -42.0% | -73.0% | -56.7% | -67.6% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 3.0 | 6.3 | 4.5 | · | 3.7 | · | 8.8 | 4.4 | 16.0 | 7.3 | 9.1 | |
| Quick Ratio | 7.0 | 2.5 | 4.6 | 4.3 | · | 3.5 | · | 1.9 | 1.1 | 15.8 | 7.1 | 8.8 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.7 | 0.4 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.5 | 0.4 | · | · | |
| Interest Coverage | · | · | 23.2 | -16.5 | · | -43.3 | · | -18.4 | -18.1 | -79.3 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.0 | 1.3 | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | |
| Receivables Turnover | · | · | 133.4 | 3.4 | · | · | · | · | · | · | · | 20.7 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.13 | $1.45 | $1.96 | $0.10 | · | $1.16 | · | $0.65 | $0.74 | $1.41 | $3.02 | $3.93 | |
| Revenue / Share | $0.41 | $0.08 | $2.90 | $0.12 | · | · | · | · | · | $0.01 | $0.02 | $3.20 | |
| Cash Flow / Share | $-0.11 | $-0.49 | $1.24 | $-1.87 | · | · | · | · | · | $-1.54 | $-2.02 | $-1.60 | |
| Cash / Share | $0.49 | $0.42 | $0.92 | $1.40 | · | $4.73 | · | $0.24 | $0.40 | $1.45 | $3.38 | $3.79 | |
| EPS (TTM) | $-0.17 | $-0.44 | $1.39 | $-1.47 | $-1.25 | $-3.09 | · | · | · | $-1.58 | $-2.68 | $-2.69 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 450.0% | -97.3% | 2652.7% | -61.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 59.4% | -34.2% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $21M | $4M | $140M | $5M | $13M | $0 | $121.0K | $257.0K | $257.0K | $257.0K | $257.0K | $1M | |
| Net Income TTM | $-9M | $-21M | $67M | $-63M | $-33M | $-55M | $-54M | $-12M | $-25M | $-30M | $-33M | $-4M | |
| Market Cap | $28M | $46M | $83M | $51M | · | $150M | · | $231M | $672M | $785M | $864M | $850M | |
| Enterprise Value | · | · | · | · | · | · | · | $235M | $675M | $741M | · | $817M | |
| P/E | -3.7 | -2.8 | 1.6 | -1.1 | -4.9 | -2.5 | · | · | · | -20.2 | -23.2 | -37.1 | |
| P/S | 1.3 | 12.3 | 0.6 | 10.0 | · | · | · | 899.7 | 2615.3 | 3054.6 | 3360.1 | 676.4 | |
| P/B | 0.6 | 0.8 | 1.1 | 15.8 | · | 6.6 | · | 7.4 | 31.4 | 22.5 | 20.6 | 25.4 | |
| P / Tangible Book | 0.6 | 0.8 | 1.1 | 18.0 | 4.4 | 6.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.2 | -1.9 | 1.4 | -0.6 | · | -3.0 | · | -8.2 | -27.4 | -26.7 | -35.2 | -89.7 | |
| P / FCF | · | · | · | · | · | -3.0 | · | -8.0 | -27.4 | -26.7 | -34.4 | -83.5 | |
| EV / EBITDA | · | · | · | · | · | · | · | -7.8 | -25.7 | -26.6 | · | -67.5 | |
| EV / FCF | · | · | · | · | · | · | · | -8.1 | -27.5 | -25.2 | · | -80.3 | |
| EV / Revenue | · | · | · | · | · | · | · | 913.9 | 2627.7 | 2882.1 | · | 650.7 | |
| Earnings Yield | -26.9% | -36.4% | 62.3% | -94.2% | -20.5% | -40.4% | · | · | · | -5.0% | -4.3% | -2.7% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $235.0K | $0 | $19M | $334.0K | $1M | $257.0K | $977.0K | $660.0K | $736.0K | $1M | $6M | $2M | $131M | $1M | $2M | $2M | |
| R&D Expense | $4M | $12M | $5M | $5M | $7M | $5M | $4M | $8M | $7M | $7M | $11M | $6M | $7M | $7M | $8M | $6M | |
| SG&A Expense | $4M | $5M | $4M | $3M | $4M | $4M | $5M | $3M | $3M | $4M | $4M | $5M | $7M | $5M | $16M | $17M | |
| Operating Expenses | $8M | $17M | $8M | $9M | $11M | $9M | $9M | $11M | $10M | $11M | $29M | $12M | $15M | $12M | $24M | $23M | |
| Operating Income | $-8M | $-17M | $11M | $-8M | $-10M | $-9M | $-8M | $-10M | $-9M | $-10M | $-23M | $-10M | $117M | $-11M | $-22M | $-22M | |
| Interest Expense | · | · | · | · | · | · | · | · | $197.0K | $205.0K | · | $212.0K | $1M | $1M | $2M | $1M | |
| Other Non-op | $15M | $-4M | $2M | $-186.0K | $3M | $3M | $4M | $7M | $-5M | $10M | $4M | $8M | $6M | $-23M | $8M | $-8M | |
| Pretax Income | · | · | $12M | $-9M | $-7M | $-5M | $-4M | $-3M | $-14M | $942.0K | $-19M | $-2M | $122M | $-34M | $-14M | $-30M | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | $15.0K | $-395.0K | $0 | $531.0K | $138.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $7M | $-21M | $12M | $-9M | $-7M | $-5M | $-4M | $-3M | $-14M | $411.0K | $-20M | $-2M | $122M | $-34M | $-14M | $-30M | |
| EPS (Basic) | $0.63 | $-0.42 | $0.25 | $-0.17 | $-1.11 | $-0.11 | $-0.09 | $-0.06 | $-0.30 | $0.01 | $-0.41 | $-0.04 | $2.56 | $-0.71 | $-0.37 | $-0.62 | |
| EPS (Diluted) | $0.63 | $-0.42 | $0.25 | $-0.17 | $-1.11 | $-0.11 | $-0.09 | $-0.06 | $-0.30 | $0.01 | $-0.32 | $-0.04 | $2.46 | $-0.71 | $-0.36 | $-0.62 | |
| Shares (Basic) | 11,824,078 | 50,957,191 | · | 49,898,892 | 6,218,614 | 49,435,500 | · | 48,618,693 | 48,511,656 | 48,245,559 | · | 47,891,996 | 47,837,393 | 47,757,246 | · | 47,503,821 | |
| Shares (Diluted) | 11,824,078 | 50,957,191 | · | 49,898,892 | 6,218,614 | 49,435,500 | · | 48,618,693 | 48,511,656 | 48,565,051 | · | 47,891,996 | 49,923,361 | 47,757,246 | · | 47,503,821 | |
| EBITDA | $-8M | $-17M | · | $-8M | $-10M | $-9M | · | $-10M | $-9M | $-10M | · | $-10M | $117M | $-11M | · | $-22M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $37M | $21M | $15M | $11M | $7M | $16M | $29M | $26M | $35M | $34M | $44M | $58M | $27M | $46M | $69M | |
| Short-term Investments | $44M | $23M | $19M | $23M | $34M | $34M | $43M | $40M | $47M | $45M | $40M | $44M | $28M | $28M | $28M | $27M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $2M | $2M | $2M | $2M | $2M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $13M | $10M | $1M | $899.0K | $786.0K | |
| Prepaid Expense | $2M | $919.0K | $263.0K | $686.0K | $2M | $1M | $2M | $2M | $1M | $2M | $6M | $3M | $3M | $2M | $3M | $4M | |
| Other Current Assets | $930.0K | $569.0K | $17.0K | $195.0K | $867.0K | $891.0K | $1M | $953.0K | $554.0K | $556.0K | $5M | $2M | $1M | $291.0K | $62.0K | $4.0K | |
| Current Assets | $56M | $63M | $40M | $49M | $56M | $52M | $72M | $80M | $95M | $102M | $102M | $129M | $146M | $60M | $79M | $104M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $103.0K | $206.0K | $309.0K | $408.0K | $770.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $25.0K | $64.0K | $7M | $6M | $5M | |
| Total Assets | $75M | $78M | $59M | $51M | $61M | $68M | $91M | $99M | $108M | $118M | $128M | $149M | $155M | $70M | $88M | $112M | |
| Accounts Payable | $3M | $6M | $2M | $3M | $6M | $4M | $5M | $5M | $5M | $9M | $7M | $3M | $3M | $6M | $6M | $7M | |
| Accrued Liabilities | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $6M | $5M | $5M | $7M | $10M | $7M | $5M | $6M | $6M | |
| Current Liabilities | $6M | $16M | $6M | $8M | $11M | $9M | $24M | $26M | $25M | $27M | $16M | $17M | $16M | $46M | $18M | $14M | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Total Liabilities | $8M | $36M | $10M | $15M | $16M | $17M | $36M | $41M | $47M | $44M | $55M | $57M | $62M | $100M | $85M | $95M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $35M | · | $34M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Paid-in Capital | $466M | $448M | $434M | $434M | $433M | $432M | $432M | $431M | $430M | $429M | $428M | $428M | $427M | $426M | $425M | $425M | |
| Retained Earnings | $-399M | $-406M | $-385M | $-397M | $-389M | $-382M | $-377M | $-372M | $-369M | $-355M | $-355M | $-336M | $-334M | $-456M | $-422M | $-408M | |
| Stockholders' Equity | $67M | $41M | $49M | $36M | $44M | $51M | $55M | $59M | $60M | $74M | $73M | $92M | $93M | $-30M | $3M | $17M | |
| Liabilities + Equity | $75M | $78M | $59M | $51M | $61M | $68M | $91M | $99M | $108M | $118M | $128M | $149M | $155M | $70M | $88M | $112M | |
| Shares Outstanding | 9,949,609 | 62,051,330 | 43,541,510 | 41,956,724 | 39,174,941 | 39,020,274 | 37,973,991 | 37,943,241 | 37,856,463 | 37,779,796 | 37,207,799 | 37,175,815 | 37,175,665 | 33,327,627 | 32,682,342 | 32,656,242 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $0 | $129.0K | $147.0K | $153.0K | $151.0K | $155.0K | $150.0K | |
| Stock-based Comp | $568.0K | $580.0K | $687.0K | $526.0K | $820.0K | $819.0K | $981.0K | $901.0K | $759.0K | $705.0K | $557.0K | $632.0K | $728.0K | $707.0K | $454.0K | $1M | |
| Operating Cash Flow | $-15M | $-8M | $18M | $-9M | $-7M | $-7M | $-10M | $765.0K | $-11M | $-4M | $-8M | $12M | $74M | $-19M | $-23M | $-23M | |
| Investing Cash Flow | $-25M | $-525.0K | $-12M | $12M | $11M | $12M | $-3M | $2M | $1M | $5M | $-2M | $-26M | $-6M | $0 | $0 | $-27M | |
| Stock Issued | · | · | $1.0K | · | · | · | $0 | · | · | · | · | $-4.0K | $4.0K | $0 | $0 | $95.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $24M | $-115.0K | $29.0K | $0 | $-14M | $-155.0K | $31.0K | $0 | $-15.0K | $-135.0K | $34.0K | $-37M | $22.0K | $0 | $-183.0K |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3308.5% | · | · | -2516.5% | -701.0% | -3350.2% | · | -1563.6% | -1255.0% | -692.5% | · | -573.4% | 88.6% | -945.3% | · | -1400.2% | |
| Net Margin | 3147.7% | · | · | -2572.2% | -504.8% | -2097.7% | · | -425.5% | -1964.4% | 29.9% | · | -99.8% | 93.0% | -2997.9% | · | -1900.1% | |
| Pretax Margin | · | · | · | -2572.2% | -504.8% | -2097.7% | · | -485.3% | -1964.4% | 68.6% | · | -99.8% | 93.0% | -2997.9% | · | -1900.1% | |
| EBITDA Margin | -3308.5% | · | · | -2516.5% | -701.0% | -3350.2% | · | -1563.6% | -1255.0% | -692.5% | · | -573.4% | 88.6% | -945.3% | · | -1400.2% | |
| ROA | 10.9% | -29.3% | · | -11.5% | -8.2% | -5.8% | · | -2.3% | -11.0% | 0.44% | · | -1.4% | 84.2% | -37.3% | · | -26.6% | |
| ROE | 13.3% | -46.4% | · | -18.1% | -13.1% | -8.6% | · | -3.7% | -18.8% | 1.9% | · | -3.2% | 176.5% | -751.7% | · | -107.9% | |
| ROIC | · | · | · | -23.1% | -21.5% | -17.0% | · | -15.5% | -15.3% | -5.6% | · | -11.0% | 125.2% | 35.7% | · | -126.7% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 3.9 | · | 5.7 | 5.2 | 5.8 | · | 3.1 | 3.7 | 3.7 | · | 7.7 | 9.0 | 1.3 | · | 7.3 | |
| Quick Ratio | 9.3 | 3.7 | · | 4.5 | 4.1 | 4.5 | · | 2.7 | 2.9 | 2.9 | · | 5.4 | 5.4 | 1.2 | · | 6.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -46.9 | -46.4 | · | -47.6 | 93.3 | -7.4 | · | -15.8 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.9 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.7 | 57.7 | 0.6 | · | 1.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.73 | $0.67 | · | $0.87 | $1.14 | $1.29 | · | $1.54 | $1.60 | $1.96 | · | $2.47 | $2.50 | $-0.90 | · | $0.53 | |
| Revenue / Share | $0.02 | $0.00 | · | $0.01 | $0.03 | $0.01 | · | $0.01 | $0.02 | $0.03 | · | $0.04 | $2.63 | $0.02 | · | $0.03 | |
| Cash Flow / Share | · | $-0.16 | · | · | · | $-0.15 | · | · | · | $-0.08 | · | · | · | $-0.40 | · | · | |
| Cash / Share | $1.05 | $0.59 | · | $0.35 | $0.28 | $0.18 | · | $0.76 | $0.69 | $0.94 | · | $1.19 | $1.56 | $0.81 | · | $2.10 | |
| EPS (TTM) | $0.29 | $-1.45 | · | $-1.48 | $-1.37 | $-0.56 | · | $-0.67 | $-0.65 | $2.11 | · | $1.35 | $0.77 | $-2.00 | · | $-1.85 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $20M | · | $3M | $3M | $3M | · | $9M | $10M | $140M | · | $136M | $136M | $6M | · | $4M | |
| Net Income TTM | $-10M | $-25M | · | $-25M | $-20M | $-27M | · | $-36M | $-35M | $101M | · | $72M | $44M | $-91M | · | $-78M | |
| Market Cap | $40M | $57M | · | $32M | $26M | $37M | · | $57M | $76M | $56M | · | $85M | $110M | $100M | · | $78M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-18M | |
| P/E | 14.0 | -0.6 | · | -0.5 | -0.5 | -1.7 | · | -2.2 | -3.1 | 0.7 | · | 1.7 | 3.8 | -1.5 | · | -1.3 | |
| P/S | 2.1 | 2.8 | · | 11.0 | 8.1 | 14.1 | · | 6.6 | 7.8 | 0.4 | · | 0.6 | 0.8 | 18.1 | · | 18.8 | |
| P/B | 0.6 | 1.4 | · | 0.9 | 0.6 | 0.7 | · | 1.0 | 1.3 | 0.7 | · | 0.9 | 1.2 | -3.3 | · | 4.6 | |
| P / Tangible Book | 0.6 | 1.4 | · | 0.9 | 0.6 | 0.7 | · | 1.0 | 1.3 | 0.7 | · | 0.9 | 1.2 | · | · | 4.8 | |
| P / Cash Flow | · | -7.0 | · | · | · | -5.0 | · | · | · | -13.9 | · | · | · | -5.3 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -4.3 | |
| Earnings Yield | 7.1% | -158.1% | · | -192.2% | -203.0% | -58.8% | · | -45.0% | -32.5% | 143.5% | · | 59.2% | 26.1% | -66.7% | · | -77.1% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $21M | $4M | $140M | $5M | $13M |
| Faaliyet Kâr Marjı % | -78.0% | -990.8% | 51.8% | -1684.5% | · |
| Net Gelir | $-9M | $-21M | $67M | $-63M | $-33M |
| Seyreltilmiş Hisse Başı Kâr | $-0.17 | $-0.44 | $1.39 | $-1.47 | $-1.25 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 7.0 | 3.0 | 6.3 | 4.5 | · |
| Cari Oran | 7.0 | 2.5 | 4.6 | 4.3 | · |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 4 dosya · $1.3M toplam · Tarih itibarıyla 31 Mart 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
4
Tutulan Değer
$1.3M
Yeni pozisyonlar
16
Çıkan pozisyonlar
6
Kurumsal faaliyet — Q1 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 16 (+10 önceki Ç'ye göre) | 6 (-3 önceki Ç'ye göre) | 8 (-2 önceki Ç'ye göre) | 11 (+3 önceki Ç'ye göre) | +21.2M |
Q4 2025 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.113.787 | 1.762.322 | 85,21% | Hisse senetleri |
| AMH Equity Ltd | $189.373 | 245.939 | 14,49% | Hisse senetleri |
| Sandy Spring Bank | $3.809 | 4.000 | 0,29% | Hisse senetleri |
| CWM, LLC | $175 | 191 | 0,01% | Hisse senetleri |
Şirket yöneticileri 29 içeriden öğrenenler · 10 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Gonzalez David Angulo | Chief Executive Officer | 01 Nisan 2026 P | 1.357.126 | 0 | 0 | $0 |
| Marco Taglietti | Chief Executive Officer | 26 Nisan 2022 A | 272.068 | 0 | 0 | $0 |
| Sanjay Subramanian | Chief Financial Officer | 09 Eylül 2026 A | · | 0 | 0 | $0 |
| Ivor Macleod | Chief Financial Officer | 29 Ocak 2026 A | 398.529 | 0 | 0 | $0 |
| Eric Francois | Chief Financial Officer | 29 Ocak 2021 A | 11.732 | 0 | 0 | $0 |
| Jr. Charles F Osborne, | Chief Financial Officer | 01 Nisan 2015 A | · | 0 | 0 | $0 |
| Scott Sukenick | Chief Legal Officer | 29 Ocak 2026 A | 574.539 | 0 | 0 | $0 |
| Christine Coyne | Chief Commercial Officer | 04 Şubat 2022 A | 58.200 | 0 | 0 | $0 |
| Carole Sable | Chief Medical Officer | 18 Haziran 2014 A | · | 0 | 0 | $0 |
| Eileen Pruette | General Counsel | 18 Haziran 2014 A | · | 0 | 0 | $0 |
| Steven Keith Burke | Yönetim kurulu üyesi | 18 Eylül 2026 A | 5.750 | 0 | 0 | $0 |
| Brian Philippe Tinmouth | Yönetim kurulu üyesi | 26 Haziran 2026 A | 12.125 | 0 | 0 | $0 |
| Guy Macdonald | Yönetim kurulu üyesi | 26 Haziran 2026 A | 12.625 | 0 | 0 | $0 |
| Ann Hanham | Yönetim kurulu üyesi | 26 Haziran 2026 A | 11.577 | 0 | 0 | $0 |
| David C Hastings | Yönetim kurulu üyesi | 26 Haziran 2026 A | 11.522 | 0 | 0 | $0 |
| Armando Anido | Yönetim kurulu üyesi | 26 Haziran 2026 A | 11.750 | 0 | 0 | $0 |
| Steven C Gilman | Yönetim kurulu üyesi | 26 Haziran 2025 A | 70.000 | 0 | 0 | $0 |
| Patrick Machado | Yönetim kurulu üyesi | 02 Ocak 2019 A | 60.000 | 0 | 0 | $0 |
| Marion Mccourt | Yönetim kurulu üyesi | 02 Temmuz 2018 A | · | 0 | 0 | $0 |
| Patrick Langlois | Yönetim kurulu üyesi | 03 Ocak 2017 A | 10.503 | 0 | 0 | $0 |
| Yves J Ribeill | Yönetim kurulu üyesi | 22 Temmuz 2015 A | 1.190 | 0 | 0 | $0 |
| Edward Penhoet | Yönetim kurulu üyesi | 04 Haziran 2015 A | · | 0 | 0 | $0 |
| Jean-Yves Nothias | Yönetim kurulu üyesi | 01 Nisan 2015 A | 295.077 | 0 | 0 | $0 |
| Pamela J Kirby | Yönetim kurulu üyesi | 01 Nisan 2015 A | 25.590 | 0 | 0 | $0 |
| Laurent Arthaud | Yönetim kurulu üyesi | 11 Haziran 2014 A | 4.507 | 0 | 0 | $0 |
| Mounia Chaoui | Yönetim kurulu üyesi | 11 Haziran 2014 A | · | 0 | 0 | $0 |
| Ventech Capital II | 10% sahip | 07 Mayıs 2014 C | 414.211 | 0 | 0 | $0 |
| F.C.P.R. Genavent | 10% sahip | 07 Mayıs 2014 C | 237.598 | 0 | 0 | $0 |
| FCPR Biotechnology Fund | 10% sahip | 07 Mayıs 2014 C | 295.077 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
SCYX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$33.00
+544,5%
3 33,3%
Güçlü Al
5 55,6%
Al
1 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-10-03Ortalama hedef $36.33 +609,6%
← Tüm hedeflerin altında
Mevcut fiyat $5.12
Düşük$32.00
Ortalama$36.33
Yüksek$44.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | · |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| IMA | · | -0.7 | -77.1% | -5668.6% | 192.1% | · |
| BSEM | · | · | · | · | · | · |
| LONA | $71M | -0.3 | · | · | -353.4% | · |
| FLNA | · | · | · | · | -112.1% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 10, 2026